Drug Shortage Report for MINT-CLOPIDOGREL
| Report ID | 45117 |
| Drug Identification Number | 02408910 |
| Brand name | MINT-CLOPIDOGREL |
| Common or Proper name | Mint- Clopidogrel |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CLOPIDOGREL |
| Strength(s) | 75MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 Count Blisters |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-04-06 |
| Estimated end date | Unknown |
| Actual end date | 2019-02-04 |
| Shortage status | Avoided shortage |
| Updated date | 2024-12-05 |
| Company comments | Discontinued- Actual start date was April 06,2018 but the drop down for year doesn't have 2018. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-12-05 | French | Compare |
| v4 | 2024-12-05 | English | Compare |
| v3 | 2018-04-07 | English | Compare |
| v2 | 2018-04-06 | French | Compare |
| v1 | 2018-04-06 | English | Compare |
Showing 1 to 5 of 5